Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies

Aims A primary objective of this study was to investigate the effect of single and multiple doses of alisertib, an investigational Aurora A kinase inhibitor, on the QTc interval in patients with advanced malignancies. The dose regimen used was the maximum tolerated dose which was also the recommende...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaofei, Nemunaitis, John, Pant, Shubham, Bauer, Todd M., Patel, Manish, Sarantopoulos, John, Craig Lockhart, A., Goodman, Daniel, Huebner, Dirk, Mould, Diane R., Venkatakrishnan, Karthik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Phase I Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869873/
https://www.ncbi.nlm.nih.gov/pubmed/28819760
http://dx.doi.org/10.1007/s10637-017-0498-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869873/
https://www.ncbi.nlm.nih.gov/pubmed/28819760
http://dx.doi.org/10.1007/s10637-017-0498-0

Ejemplares similares